3E013TZ
3E013TZ: Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduction of Destructive Agent into Subcu, Perc Approach
How 3E013TZ is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration: What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective: the verb of the procedure
- 1Body partThe specific site
- 3ApproachHow the site was reached
- TDeviceWhat was left in place, if anything
- ZQualifierA further distinction where one applies
Codes near 3E013TZ
In CMS’s own ordering, which groups codes that differ by only the last character or two, usually the approach, device or qualifier.
- 3E0134ZIntroduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach
- 3E0136ZIntroduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E0137ZIntroduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013BZIntroduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach
- 3E013GCIntroduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013HZIntroduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013KZIntroduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
- 3E013NZIntroduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach
- 3E013TZIntroduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach
- 3E013VGIntroduction of Insulin into Subcutaneous Tissue, Percutaneous Approach
- 3E013VJIntroduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach
- 3E01XGFIntroduction of Other Enzymatic/Chemical Agent into Subcutaneous Tissue, External Approach
- 3E02305Introduction of Other Antineoplastic into Muscle, Percutaneous Approach
- 3E0230MIntroduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach
- 3E02328Introduction of Oxazolidinones into Muscle, Percutaneous Approach
- 3E02329Introduction of Other Anti-infective into Muscle, Percutaneous Approach
- 3E0233ZIntroduction of Anti-inflammatory into Muscle, Percutaneous Approach